Journal
/
Pesquisa do Câncer
/
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
JoVE Journal
Pesquisa do Câncer
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Pesquisa do Câncer
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

DOI:
10.3791/58270-v

•

09:52 min

•

December 04, 2018

•

, , , , , , , , ,
1Dept. of Hematology, Oncology and Immunology,University of Tübingen, 2Dept. of Endocrinology, Diabetology, Clinical Pathology and Metabolism,University of Tübingen

Capítulos

  • 00:04Título
  • 00:41Fixation, Cell Lysis, and Chromatin Shearing
  • 03:54Chromatin Immunoprecipitation
  • 08:31Results: qRT-PCR with Precipitated DNA Identified Specific Binding of NFAT2 to the LCK Promotor Region
  • 09:30Conclusion

Summary

Tadução automática

Tadução automática

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. NFAT transcription factors are important regulators of development and activation in numerous cell types. Here, we present a protocol for the use of chromatin immunoprecipitation (ChIP) in human CLL cells to identify novel target genes of NFAT2.

Tags

Chromatin ImmunoprecipitationNFAT2Chronic Lymphocytic LeukemiaTranscription FactorsTarget GenesFixationShearingCell LysisSonicationProtease Inhibitor

Article

Embed

ADICIONAR À PLAYLIST

Usage Statistics

Vídeos Relacionados

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Native Chromatin Immunoprecipitation Using Murine Brain Tumor Neurospheres

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Assessment of the Metabolic Profile of Primary Leukemia Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

In Vitro Assay to Study Tumor-macrophage Interaction

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Read Article